期刊文献+

益生菌辅助治疗儿童支气管哮喘伴变应性鼻炎的疗效及机制研究 被引量:14

The Efficacy and Mechanism of Probiotics in Children with Bronchial Asthma Combined with Allergic Rhinitis
下载PDF
导出
摘要 目的:探讨益生菌辅助治疗儿童支气管哮喘伴变应性鼻炎(AR)的疗效及机制。方法:选取100例哮喘伴AR患儿,随机分为观察组和对照组各50例,对照组给予常规治疗,观察组在对照组治疗基础上联合双歧杆菌乳杆菌三联活菌散治疗,连续治疗6个月。比较两组患儿哮喘控制测试(C-ACT)量表评分、第1秒用力肺活量(FEV1)、呼气峰值流速(PEF)、鼻部症状评分及血清干扰素-γ(IFN-γ)和白介素-4(IL-4)水平。结果:治疗后,观察组C-ACT评分、FEV1、PEF、鼻部症状评分、IFN-γ及IL-4分别为(24.6±2.3)分、123.7%±10.6%、(125.2±8.3)L/min、(0.5±0.2)分、(43.6±4.8)g/L及(32.4±3.9)ng/L,对照组分别为(20.1±2.0)分、108.4%±14.3%、(110.8±7.4)L/min、(0.9±0.3)分、(35.2±3.9)g/L及(44.8±4.7)ng/L,与对照组比较,观察组C-ACT评分、FEV1、PEF、IFN-γ提高(P<0.05),同时鼻部症状评分及IL-4降低(P<0.05)。结论:益生菌辅助治疗哮喘伴AR可有效缓解临床症状,纠正Th1/Th2免疫失衡是其可能的作用机制。 Objective: To investigate the efficacy and mechanism of probiotics in children with bronchial asthma combined with allergic rhinitis(AR).Methods: One hundred children with bronchial asthma combined with AR were divided into observation group(n = 50)and control group(n = 50).The control group was treated with conventional therapy,and the observation group was treated with conventional therapy combined with live combined bifidobacterium and lactobacillus tablets,for 6 months.The asthma control test(CACT) score,forced expiratory volume in 1 s(FEV1),peak expiratory flow(PEF),nasal symptom scores,interferon-γ(IFN-γ) and interleukin-4(IL-4) level were compared between the two groups.Results: The C-ACT score,FEV1,PEF,nasal symptom scores,IFN-γ and IL-4 of observation group respectively were(24.6 ± 2.3) scores,123.7% ± 10.6%,(125.2 ± 8.3) L / min,(0.5 ± 0.2)scores,(43.6±4.8) g / L and(32.4 ± 3.9) ng / L,those of control group respectively were(20.1 ± 2.0) scores,108.4% ± 14.3%,(110.8±7.4) L/min,(0.9±0.3) scores,(35.2± 3.9) g/L and(44.8± 4.7) ng/L.Compared with control group,the C-ACT,FEV1,PEF and IFN-γ of observation group significantly increased(P0.05),and the nasal symptom scores and IL-4 of control group significantly decreased(P〈0.05).Conclusion: Probiotics adjuvant therapy on bronchial asthma combined with AR can effectively relieve the clinical symptoms,regulating Th1 / Th2 immune imbalance may be its mechanism.
出处 《儿科药学杂志》 CAS 2016年第12期26-29,共4页 Journal of Pediatric Pharmacy
关键词 支气管哮喘 变应性鼻炎 益生菌 TH1/TH2 bronchial asthma allergic rhinitis probiotics Th1/Th2
  • 相关文献

参考文献11

二级参考文献117

共引文献4407

同被引文献101

引证文献14

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部